These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 30723410)

  • 41. Destabilization of KLF10, a tumor suppressor, relies on thr93 phosphorylation and isomerase association.
    Hwang YC; Yang CH; Lin CH; Ch'ang HJ; Chang VHS; Yu WCY
    Biochim Biophys Acta; 2013 Dec; 1833(12):3035-3045. PubMed ID: 23994618
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pin1 dysregulation helps to explain the inverse association between cancer and Alzheimer's disease.
    Driver JA; Zhou XZ; Lu KP
    Biochim Biophys Acta; 2015 Oct; 1850(10):2069-76. PubMed ID: 25583562
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pin1 Is Involved in HDAC6-mediated Cancer Cell Motility.
    Chuang HH; Huang MS; Wang PH; Liu YP; Hsiao M; Yang CJ
    Int J Med Sci; 2018; 15(13):1573-1581. PubMed ID: 30443180
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pin1 interacts with a specific serine-proline motif of hepatitis B virus X-protein to enhance hepatocarcinogenesis.
    Pang R; Lee TK; Poon RT; Fan ST; Wong KB; Kwong YL; Tse E
    Gastroenterology; 2007 Mar; 132(3):1088-103. PubMed ID: 17383430
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Phosphorylation-specific peptidyl-prolyl isomerization of neuronal cytoskeletal proteins by Pin1: implications for therapeutics in neurodegeneration.
    Rudrabhatla P; Pant HC
    J Alzheimers Dis; 2010; 19(2):389-403. PubMed ID: 20110589
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Targeting PIN1 as a Therapeutic Approach for Hepatocellular Carcinoma.
    Cheng CW; Tse E
    Front Cell Dev Biol; 2019; 7():369. PubMed ID: 32010690
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Modulating the Affinities of Phosphopeptides for the Human Pin1 WW Domain Using 4-Substituted Proline Derivatives.
    Huang KY; Horng JC
    Biochemistry; 2015 Oct; 54(40):6186-94. PubMed ID: 26406962
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Functionally important residues in the peptidyl-prolyl isomerase Pin1 revealed by unigenic evolution.
    Behrsin CD; Bailey ML; Bateman KS; Hamilton KS; Wahl LM; Brandl CJ; Shilton BH; Litchfield DW
    J Mol Biol; 2007 Jan; 365(4):1143-62. PubMed ID: 17113106
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pin1 Modulates the Synaptic Content of NMDA Receptors via Prolyl-Isomerization of PSD-95.
    Antonelli R; De Filippo R; Middei S; Stancheva S; Pastore B; Ammassari-Teule M; Barberis A; Cherubini E; Zacchi P
    J Neurosci; 2016 May; 36(20):5437-47. PubMed ID: 27194325
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Dynamical role of phosphorylation on serine/threonine-proline Pin1 substrates from constant force molecular dynamics simulations.
    Velazquez HA; Hamelberg D
    J Chem Phys; 2015 Feb; 142(7):075102. PubMed ID: 25702031
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pin1 Inhibitor Juglone Exerts Anti-Oncogenic Effects on LNCaP and DU145 Cells despite the Patterns of Gene Regulation by Pin1 Differing between These Cell Lines.
    Kanaoka R; Kushiyama A; Seno Y; Nakatsu Y; Matsunaga Y; Fukushima T; Tsuchiya Y; Sakoda H; Fujishiro M; Yamamotoya T; Kamata H; Matsubara A; Asano T
    PLoS One; 2015; 10(6):e0127467. PubMed ID: 26039047
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cysteine-mediated dynamic hydrogen-bonding network in the active site of Pin1.
    Barman A; Hamelberg D
    Biochemistry; 2014 Jun; 53(23):3839-50. PubMed ID: 24840168
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prevalent overexpression of prolyl isomerase Pin1 in human cancers.
    Bao L; Kimzey A; Sauter G; Sowadski JM; Lu KP; Wang DG
    Am J Pathol; 2004 May; 164(5):1727-37. PubMed ID: 15111319
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Binding and regulation of the transcription factor NFAT by the peptidyl prolyl cis-trans isomerase Pin1.
    Liu W; Youn HD; Zhou XZ; Lu KP; Liu JO
    FEBS Lett; 2001 May; 496(2-3):105-8. PubMed ID: 11356192
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pin1 Modulation in Physiological Status and Neurodegeneration. Any Contribution to the Pathogenesis of Type 3 Diabetes?
    Bianchi M; Manco M
    Int J Mol Sci; 2018 Aug; 19(8):. PubMed ID: 30096758
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Mutations in proline 82 of p53 impair its activation by Pin1 and Chk2 in response to DNA damage.
    Berger M; Stahl N; Del Sal G; Haupt Y
    Mol Cell Biol; 2005 Jul; 25(13):5380-8. PubMed ID: 15964795
    [TBL] [Abstract][Full Text] [Related]  

  • 57. How does Pin1 catalyze the cis-trans prolyl peptide bond isomerization? A QM/MM and mean reaction force study.
    Vöhringer-Martinez E; Duarte F; Toro-Labbé A
    J Phys Chem B; 2012 Nov; 116(43):12972-9. PubMed ID: 23030417
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Conformation-directed catalysis and coupled enzyme-substrate dynamics in Pin1 phosphorylation-dependent cis-trans isomerase.
    Velazquez HA; Hamelberg D
    J Phys Chem B; 2013 Oct; 117(39):11509-17. PubMed ID: 23980573
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The prolyl isomerase Pin1 interacts with a ribosomal protein S6 kinase to enhance insulin-induced AP-1 activity and cellular transformation.
    Lee NY; Choi HK; Shim JH; Kang KW; Dong Z; Choi HS
    Carcinogenesis; 2009 Apr; 30(4):671-81. PubMed ID: 19168580
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Exploring the molecular function of PIN1 by nuclear magnetic resonance.
    Landrieu I; Smet C; Wieruszeski JM; Sambo AV; Wintjens R; Buée L; Lippens G
    Curr Protein Pept Sci; 2006 Jun; 7(3):179-94. PubMed ID: 16787258
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.